CRISPR technique skips over portions of genes that can cause disease
Researchers have adapted CRISPR to cause the cell's internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building...
List view / Grid view
Researchers have adapted CRISPR to cause the cell's internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building...
Scientists have made an important step towards understanding the mechanisms that cause the neurodegenerative disorder Huntington's disease...
Researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition...
Scientists have applied their high-throughput, multi-pronged approach to Huntington's disease, and uncovered the functional significance of various molecular changes...
Epigenomic analyses may lead to other unexpected findings and novel therapeutic drug targets for many diseases
Researchers create eye neuron network model to study retinal diseases, possible treatment options...
Scientists have developed a breakthrough CRISPR gene-editing tool, that could allow researchers to quickly and precisely engineer multiple changes to the genetic code...
Findings could deepen understanding of neurological disorders...
Using genetic engineering technology, a team of scientists have established an animal model of Huntington's disease...
Improvements to gene-editing techniques hold promise for inactivating the defective gene responsible for this as-yet incurable disease...
Scientists have discovered why Huntington's is so toxic to cancer cells and harnessed it for a novel approach to treat cancer...
Scientists have transformed skin cells from patients with Huntington's disease into the type of brain cell affected by the disorder...
Researchers have developed a system to model Huntington's in human embryonic stem cells...
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial…
The first data network for this research could also be the blueprint for similar data networks for research into other conditions...